Ebola | |||||
NEWS | |||||
New study of Ebola survivors reveals more on long-term effects of the virus A group of French scientists has analyzed the aftereffects of the Ebola virus on survivors. Their research revealed heightened levels of immunitary and ...
| |||||
Dry Powder Inhalation Could Be a Potent Tool in COVID-19 Antiviral Treatment Originally developed to treat the Ebola virus disease, remdesivir has shown promising results treating COVID-19 in the human airway epithelial cells.
| |||||
Kansas State University developing vaccine for African Swine Fever The exact same symptoms that you read about for Ebola in humans is exactly what African swine fever does to pigs. It's only a pig disease but then it's ...
| |||||
'It has to work': COVID-19 vaccine researchers' high-stakes quest It took a second Ebola epidemic in 2014 for trials to be resumed and brought to completion, resulting in J&J receiving marketing authorization from the ...
| |||||
What funds are needed to prevent another pandemic? Just 2% of COVID-19's estimated cost ... from the 2003 SARS outbreak to the more recent outbreaks of Ebola. But the COVID-19 crisis has surpassed these outbreaks not just in the number ...
| |||||
Antibiotics Market To Reach USD 63.34 Billion By 2026 | CAGR of 3.5% |Bristol-Myers Squibb Co ... Moreover, the development of new infections, such as the Ebola virus and Zika, are also promoting the development and growth of the antibiotics ...
| |||||
Covid-19 cure claim: Critics go for Dr Stella Emmanuel's throat "This is doctor Fauci who insisted on treating Ebola patients himself to show staff who were afraid that he would never ask them to do what he would ...
| |||||
Grifols delivers first manufactured batches of its anti-SARS-CoV-2 hyperimmune globulin for ... During the Ebola outbreak in Liberia in 2014, Grifols collected convalescent plasma and designed and activated a plant in Clayton, North Carolina, ...
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar